By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Bill and Melinda Gates Foundation and Grand Challenges Canada have pumped $31.5 million into new research projects to develop point-of-care technologies, including PCR and microfluidics-based tools for diagnosing diseases, the Gates Foundation said yesterday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.